Excellence in viral hepatitis elimination - Lessons from Georgia

Affiliations

¹ Centers for Disease Control and Prevention, Division of Viral Hepatitis National Center for HIV, Hepatitis, STD and TB Prevention, Atlanta, USA.
² Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain; European Association for the Study of the Liver (EASL) International Liver Foundation, Geneva, Switzerland.
³ Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health, and Social Affairs of Georgia, Tbilisi, Georgia.
⁴ European Association for the Study of the Liver (EASL) International Liver Foundation, Geneva, Switzerland.
⁵ National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia.
⁶ Infection Diseases, AIDS, and Clinical Immunology Research Center, Tbilisi, Georgia.
⁷ Neolab, Tbilisi, Georgia.
⁸ Medical Center Mrcheveli, Tbilisi, Georgia.
⁹ Joint Georgian-French Hepatology Clinic Hepa, Tbilisi, Georgia.
¹⁰ Burnet Institute, Melbourne, Australia.
¹¹ Centers for Disease Control and Prevention, Division of Viral Hepatitis National Center for HIV, Hepatitis, STD and TB Prevention, Atlanta, USA. Electronic address: snasrullah@cdc.gov.

Editorial

Francisco Averhoff et al. J Hepatol. 2019 Oct.

. 2019 Oct;71(4):645-647.

doi: 10.1016/j.jhep.2019.06.026. Epub 2019 Jul 26.

¹ Centers for Disease Control and Prevention, Division of Viral Hepatitis National Center for HIV, Hepatitis, STD and TB Prevention, Atlanta, USA.
² Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain; European Association for the Study of the Liver (EASL) International Liver Foundation, Geneva, Switzerland.
³ Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health, and Social Affairs of Georgia, Tbilisi, Georgia.
⁴ European Association for the Study of the Liver (EASL) International Liver Foundation, Geneva, Switzerland.
⁵ National Center for Disease Control and Public Health of Georgia, Tbilisi, Georgia.
⁶ Infection Diseases, AIDS, and Clinical Immunology Research Center, Tbilisi, Georgia.
⁷ Neolab, Tbilisi, Georgia.
⁸ Medical Center Mrcheveli, Tbilisi, Georgia.
⁹ Joint Georgian-French Hepatology Clinic Hepa, Tbilisi, Georgia.
¹⁰ Burnet Institute, Melbourne, Australia.
¹¹ Centers for Disease Control and Prevention, Division of Viral Hepatitis National Center for HIV, Hepatitis, STD and TB Prevention, Atlanta, USA. Electronic address: snasrullah@cdc.gov.

No abstract available

Keywords: Georgia; Hepatitis C; Hepatitis elimination; Monitoring and evaluation.

Publication types